Das Kantonsspital Winterthur dient der medizinischen Versorgung der Region Winterthur im Kanton Zürich. Die öffentlich-rechtliche Einrichtung ist mit rund 500 Betten der zehntgrösste Spitalbetrieb in der Schweiz und behandelt jährlich rund 200'000 stationäre und ambulante Patienten.

During the past decade, Kantonsspital Winterthur conducted 93 clinical trials. In the 10-year time frame, 93 clinical trials started and 16 clinical trials were completed, i.e. on average, 17.2% percent of trials that started reached the finish line to date. In the past 5 years, 41 clinical trials started and 11 clinical trials were completed. i.e. 26.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kantonsspital Winterthur" #1 sponsor was "Swiss Group for Clinical Cancer Research" with 48 trials, followed by "Kantonsspital Winterthur KSW" with 20 trials sponsored, "ETOP IBCSG Partners Foundation" with 11 trials sponsored, "Pfizer" with 7 trials sponsored and "University of Zurich" with 7 trials sponsored. Other sponsors include 47 different institutions and companies that sponsored additional 43 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kantonsspital Winterthur" #1 collaborator was "Hoffmann-La Roche" with 6 trials as a collaborator, "Kantonsspital Winterthur KSW" with 6 trials as a collaborator, "Cantonal Hospital of St. Gallen" with 5 trials as a collaborator, "Breast International Group" with 4 trials as a collaborator and "Cancer Trials Ireland" with 4 trials as a collaborator. Other collaborators include 150 different institutions and companies that were collaborators in the rest 136 trials.

According to Clinical.Site data, the most researched conditions in "Kantonsspital Winterthur" are "Breast Cancer" (12 trials), "Lung Cancer" (10 trials), "Prostate Cancer" (7 trials), "Colorectal Cancer" (6 trials) and "Lymphoma" (5 trials). Many other conditions were trialed in "Kantonsspital Winterthur" in a lesser frequency.

Most popular intervention types in "Kantonsspital Winterthur" are "Drug" (85 trials), "Radiation" (15 trials), "Device" (14 trials), "Other" (14 trials) and "Procedure" (14 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Carboplatin" (6 trials), "Bevacizumab" (5 trials), "Gemcitabine" (5 trials) and "Rituximab" (5 trials). Other intervention names were less common.

The vast majority of trials in "Kantonsspital Winterthur" are 116 trials for "All" genders, 16 trials for "Female" genders and 11 trials for "Male" genders.

Currently, there are NaN active trials in "Kantonsspital Winterthur". undefined are not yet recruiting, 31 are recruiting, 36 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 52 completed trials in Kantonsspital Winterthur, 1 suspended trials, and 17 terminated clinical trials to date.

Out of the total trials that were conducted in Kantonsspital Winterthur, 5 "Phase 1" clinical trials were conducted, 47 "Phase 2" clinical trials and 42 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 27 trials that are defined as “Not Applicable".

Kantonsspital Winterthur has several departments that took part in Clinical trials: "Kantonsspital Winterthur Medizinische Onkologie" - 6 trials